Investors House hosted a webcast CMD on 20 March. The company gave an update on current operations o...
Redeye states that Q4 came in on the weak side and that the outlook for Q1 was weak, but far from ca...
On March 20, 2023, Brain+ A/S (“Brain+” or “the Company”) announced that the Danish municipality Her...
EcoRub tillkännagav den 2 mars att bolaget lanserar en ny produktserie riktad till hästägare under v...
Redeye updates its view on Energy Save after the Q3 2022/2023 report.
Redeye comments on Aritificial Solutions Q4’22 report.
Redeye comments on the fact that Flexion Mobile is partnering with Digital Turbine by adding another...
CoinShares International (CS) reported a moderate £6.
Scandinavian Astor Group meddelade den 16 mars att bolaget har ingått ett avtal om toppgarantiåtagan...
Redeye is viewing the progress in bringing Carbonhand to the market as encouraging.
Fluicell AB (publ) (”Fluicell” or “the Company”) offers innovative R&D instruments for both single-c...
Redeye takes a mixed stance towards Speqta’s proposed dividend of SEK45m.
Redeye updates its view on Amniotics following the 2023 rights issue and new strategy focusing on bu...
Redeye comments on Energy Save’s Q3’22/23 report, which once again showed superior growth (157% y/y)...
Redeye concludes that Q4 was weaker than expected. Revenue was 5% below expectations, where recurrin...
Nordea released Finnish card spending data until end of February today.
En förvärvare av högkvalitativa bolag inom media och tech Vi inleder bevakning av VO2 Cap Holding, e...
Recyctec fortsätter växa med ett fortsatt fokus på försäljning, både på den inhemska och utländska m...
2023e order book forecast increased by 4% 2023e-24e revenue, EBIT (before s.
Redeye believes the new biomarker results with nadunolimab to be presented at the AACR Annual Meetin...
